Adherence to guidelines regarding anticoagulation and risk factors for progression of atrial fibrillation in a nurse-led clinic.
alcohol consumption
atrial fibrillation
disease progression
guideline adherence
obesity
Journal
Internal medicine journal
ISSN: 1445-5994
Titre abrégé: Intern Med J
Pays: Australia
ID NLM: 101092952
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
revised:
06
04
2020
received:
01
09
2019
accepted:
08
04
2020
pubmed:
3
5
2020
medline:
10
8
2021
entrez:
3
5
2020
Statut:
ppublish
Résumé
Atrial fibrillation (AF) is the commonest cardiac arrhythmia associated with an increased risk of stroke. Evidence suggests that management in a specialty clinic improves clinical outcomes of patients. To assess level of adherence to evidence-based guidelines regarding anticoagulation and the risk factors for progression of AF in a nurse-led AF clinic. A retrospective analysis was conducted on clinical records of 136 patients seen at the AF clinic to determine their risk factors and progression of AF (change in AF type to more advanced types) during follow up. Additionally, the proportion of patients with CHA Rate of anticoagulation in patients with CHA Management of AF in a nurse-led clinic was associated with high level of adherence to anticoagulation guidelines. Age, obesity and excessive alcohol intake were significant predictors for progression of AF.
Sections du résumé
BACKGROUND
Atrial fibrillation (AF) is the commonest cardiac arrhythmia associated with an increased risk of stroke. Evidence suggests that management in a specialty clinic improves clinical outcomes of patients.
AIMS
To assess level of adherence to evidence-based guidelines regarding anticoagulation and the risk factors for progression of AF in a nurse-led AF clinic.
METHODS
A retrospective analysis was conducted on clinical records of 136 patients seen at the AF clinic to determine their risk factors and progression of AF (change in AF type to more advanced types) during follow up. Additionally, the proportion of patients with CHA
RESULTS
Rate of anticoagulation in patients with CHA
CONCLUSIONS
Management of AF in a nurse-led clinic was associated with high level of adherence to anticoagulation guidelines. Age, obesity and excessive alcohol intake were significant predictors for progression of AF.
Substances chimiques
Anticoagulants
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1136-1142Informations de copyright
© 2020 Royal Australasian College of Physicians.
Références
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991; 22: 983-8.
Ball J, Thompson DR, Ski CF, Carrington MJ, Gerber T, Stewart S. Estimating the current and future prevalence of atrial fibrillation in the Australian adult population. Med J Aust 2015; 202: 32-5.
Group NCAFGW, Brieger D, Amerena J, Attia J, Bajorek B, Chan KH et al. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018. Heart Lung Circ 2018; 27: 1209-66.
Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European heart rhythm association. Eur Heart J 2012; 33: 2719-47.
Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016; 37: 2893-962.
Hendriks JM, de Wit R, Crijns HJ, Vrijhoef HJ, Prins MH, Pisters R et al. Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation. Eur Heart J 2012; 33: 2692-9.
Tran HN, Tafreshi J, Hernandez EA, Pai SM, Torres VI, Pai RG. A multidisciplinary atrial fibrillation clinic. Curr Cardiol Rev 2013; 9: 55-62.
Carter L, Gardner M, Magee K, Fearon A, Morgulis I, Doucette S et al. An integrated management approach to atrial fibrillation. J Am Heart Assoc 2016; 5: e002950.
Farshid A, Hastie C, McManus M. Nurse-led, protocol-based atrial fibrillation clinic results in excellent compliance with guidelines. Heart Lung Circ 2017; 26: S298.
Jahangir A, Lee V, Friedman PA, Trusty JM, Hodge DO, Kopecky SL et al. Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation 2007; 115: 3050-6.
Pathak RK, Middeldorp ME, Meredith M, Mehta AB, Mahajan R, Wong CX et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY). J Am Coll Cardiol 2015; 65: 2159-69.
Voskoboinik AWG, Lee G, Nalliah C, Hawson J, Prabhu S et al. Moderate alcohol consumption is associated with atrial electrical and structural changes: insights from high-density left atrial electroanatomic mapping. Heart Rhythm 2019; 16: 251-9.
Verdecchia P, Angeli F, Reboldi G. Hypertension and atrial fibrillation: doubts and certainties from basic and clinical studies. Circ Res 2018; 122: 352-68.
National Health and Medical Research Council (NHMRC). Australian Guidelines to Reduce Health Risks from Drinking Alcohol. NHMRC: Canberra; 2009.
Diouf I, Magliano DJ, Carrington MJ, Stewart S, Shaw JE. Prevalence, incidence, risk factors and treatment of atrial fibrillation in Australia: the Australian diabetes, obesity and lifestyle (AusDiab) longitudinal, population cohort study. Int J Cardiol 2016; 205: 127-32.
Gibbs H, Kakkar A. Australian treatment patterns in atrial fibrillation: results from the global anticoagulation in the field (GARFIELD) registry. Heart Lung Circ 2015; 24: S375.
Holt TA, Hunter TD, Gunnarsson C, Khan N, Cload P, Lip GY. Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey. Br J Gen Pract 2012; 62: e710-17.
Marzec LN, Wang J, Shah ND, Chan PS, Ting HH, Gosch KL et al. Influence of direct Oral anticoagulants on rates of oral anticoagulation for atrial fibrillation. J Am Coll Cardiol 2017; 69: 2475-84.
Rush KL, Burton L, Schaab K, Lukey A. The impact of nurse-led atrial fibrillation clinics on patient and healthcare outcomes: a systematic mixed studies review. Eur J Cardiovasc Nurs 2019; 18: 526-33.
Gallagher C, Elliott AD, Wong CX, Rangnekar G, Middeldorp ME, Mahajan R et al. Integrated care in atrial fibrillation: a systematic review and meta-analysis. Heart 2017; 103: 1947-53.
Jacob L. Nurse-led clinics for atrial fibrillation: managing risk factors. Br J Nurs 2017; 26: 1245-8.
Hendriks JM, Vrijhoef HJ, Crijns HJ, Brunner-La Rocca HP. The effect of a nurse-led integrated chronic care approach on quality of life in patients with atrial fibrillation. Europace 2014; 16: 491-9.
Minakakis T. Easing the economic burden of atrial fibrillation: making the case for a structured clinical nurse specialist-led outpatient clinic. Can J Cardiovasc Nurs 2016; 26: 11-17.
Chen Q, Yi Z, Cheng J. Atrial fibrillation in aging population. Aging Med (Milton) 2018; 1: 67-74.
Middeldorp ME, Pathak RK, Meredith M, Mehta AB, Elliott AD, Mahajan R et al. PREVEntion and regReSsive effect of weight-loss and risk factor modification on atrial fibrillation: the REVERSE-AF study. Europace 2018; 20: 1929-35.
Hatem SN, Sanders P. Epicardial adipose tissue and atrial fibrillation. Cardiovasc Res 2014; 102: 205-13.
Larsson SC, Drca N, Wolk A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. J Am Coll Cardiol 2014; 64: 281-9.
Ruigomez A, Johansson S, Wallander MA, Garcia Rodriguez LA. Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK. BMC Cardiovasc Disord 2005; 5: 20.
Freedman B, Martinez C, Katholing A, Rietbrock S. Residual risk of stroke and death in anticoagulant-treated patients with atrial fibrillation. JAMA Cardiol 2016; 1: 366-8.
Rohla M, Weiss TW, Pecen L, Patti G, Siller-Matula JM, Schnabel RB et al. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European registry in atrial fibrillation (PREFER in AF). BMJ Open 2019; 9: e022478.